1. Lupus Nephritis
Hussein Sheashaa, MD, FACP
Professor of Nephrology, Urology and Nephrology Center and Director of
Medical E-Learning Unit, Mansoura University, ESNT-CME Chair and Executive
Director of ESNT- Virtual Academy: http://lms.mans.edu.eg/esnt/
GN Master Class, Monday, 21 October, 2019
20. Proliferative Lupus N:
Histological Versus Clinical Remission
Nephrol Dial Transplant (2017) 32: 1338–1344
One-third of patients who achieved a complete clinical response
after induction had persistently high histologic activity
62% of patients who had complete histologic remission
on rebiopsy were still clinically active.
29. Lupus Nephritis:
Impact of Antiphospholipid Antibodies
Lupus (2019) 28, 1460–1467
53/149 (35.6%) patients with biopsy-proven LN
30. Medicine (Baltimore). 2017 Sep;96(37):e8024.
LN Outcome Prediction:
Score System
< 10 11-20 > 20 incidences of ESRD in these 3 groups
were 2.7%, 32.5%, and 79.4%,
33. Treatment of LN:
Principles
As early as possible
Aggressive enough to obtain complete remission
Able to prevent renal flare
Delay or prevent progression to ESRD
Infection/
MalignancyDisease
Control